ClinicalTrials.Veeva

Menu
A

Angel City Research | Los Angeles, CA

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Relamorelin
Semaglutide
Suzetrigine
TQJ230
SUZ
CIN-102
Deudomperidone
NG101

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

10 of 19 total trials

A Modified Platform Trial of Multiple CAMPs for the Management of Diabetic Foot Ulcers and Venous Leg Ulcers

The purpose of this study is to determine how well multiple CAMPs (Cellular, Acellular and Matrix-Like Products) and Standard of Care work when compa...

Enrolling
Venous Leg Ulcer
Diabetic Foot Ulcer
Device: AmnioExcel Plus for Venous Leg Ulcers
Device: Urinary Bladder Matrix (UBM) sheet device for Venous Leg Ulcers

The goal of this clinical trial is to evaluate if the study drug CIN-102 (deudomperidone) can help reduce the symptoms associated with diabetic gastr...

Enrolling
Diabetic Gastroparesis
Drug: Placebo
Drug: CIN-102 Dose 15mg or 10mg

The purpose of this study is to evaluate the efficacy, safety, and tolerability of Suzetrigine (SUZ) in participants with pain associated with diabet...

Enrolling
Diabetic Peripheral Neuropathic Pain
Drug: Suzetrigine
Drug: Placebo (matched to Pregabalin)

The purpose of this study is to evaluate the long-term safety and tolerability of SUZ and long-term effectiveness of SUZ in treating pain associated...

Invitation-only
Diabetic Peripheral Neuropathic Pain
Drug: Suzetrigine

A multi-center, prospective, observer-blinded, randomized controlled clinical trial to evaluate the efficacy of PPECM augmented standard of care vers...

Enrolling
Ulcer
Wound Heal
Device: InnovaMatrix® AC

Study CTQJ230A12303 is a randomized, double-blind placebo-controlled, Phase IIIb study to evaluate the efficacy, safety and tolerability of pelacarse...

Enrolling
Elevated Lp(a) and Established Atherosclerotic Cardiovascular Disease
Drug: TQJ230
Drug: Placebo

The purpose of this clinical investigation is to evaluate the safety and efficacy of Amnion/Chorion/Amnion allograft , Amnion/Chorion allograft, and/...

Enrolling
Chronic Foot Ulcers
Diabetic Foot Ulcer (DFU)
Other: Allograft

The purpose of this study is to assess the safety and efficacy of SkinTE for treatment of Wagner grade 1 diabetic foot ulcers.

Enrolling
Diabetic Foot
Biological: SkinTE
Other: Control

The purpose of this clinical trial is to evaluate the safety and effectiveness of the treatment with the COMS One device in subjects with refractory...

Enrolling
Diabetic Foot Ulcer
Device: COMS One device
Device: Sham device

This study is conducted to see if ziltivekimab reduces the risk of having cardiovascular events (for example heart attack and stroke) in people with...

Active, not recruiting
Chronic Kidney Disease
Inflammation
Drug: Placebo (Ziltivekimab B)
Drug: Placebo (Ziltivekimab C)

Trial sponsors

Allergan logo
Novo Nordisk logo
Vertex Pharmaceuticals logo
C
Convatec logo
F
G
Integra LifeSciences logo
N
Novartis logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems